Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1993-6-21
|
pubmed:abstractText |
1. The present experiments were undertaken in order to characterize further the apparently irreversible inhibition of the contraction of depolarized rat aorta caused by lacidipine, a 1,4-dihydropyridine calcium antagonist. 2. We studied the effect of lacidipine on contraction evoked by 100 mM KCl solution in rat aorta, treated by N omega-nitro-L-arginine (0.1 mM), an inhibitor of nitric oxide (NO) synthesis. We compared the effect of prolonged depolarization on lacidipine and (+)-isradipine inhibition and the reversal of this inhibition after washout in the absence of dihydropyridines. Assuming that the onset of lacidipine-evoked inhibition was a pseudo-first order association kinetics, we estimated the dissociation rate constant (k-1 = 0.031 min-1), the association rate constant (k1 = 2.70 x 10(8) M-1 min-1) and the dissociation constant (KD = k-1/k1 = 115 pM) which was close to the IC50 value in steady-state conditions (160 pM). 3. The inhibitory effects of lacidipine and (+)-isradipine on rat aorta contraction were reversibly enhanced after preincubation with the drug in a 40 mM KCl-solution. Washout with drug-free 40 mM K(+)-depolarizing solution reversed inhibition in the (+)-isradipine-treated preparations, but not in the lacidipine-treated ones. 4. Radioligand binding studies were performed with [3H]-lacidipine and [3H]-isradipine in microsomes from rat aorta and rat ileum. Both ligands bound to a homogeneous population of binding sites (for[3H]-lacidipine: KD = 23 +/- 2.6 pM, Bmax = 380 +/- 21 fmol mg-1 protein in membranes from aorta; KD =23 +/- 3.1 pM, Bmax = 790 +/- 60 fmol mg-1 protein in membranes from ileum; for [3H]-isradipine:KD = 140 +/- 46 pM, Bmax = 350 +/- 64 fmol mg-1 protein in membrane from aorta; KD = 68 +/- 14 pM,Bmax = 760 +/- 75 fmol mg-1 protein in membranes from ileum). After isotopic dilution, [3H]-lacidipine and [3H]-isradipine dissociated according to a monoexponential kinetics. In membranes from ileum, the calculated dissociation rate constants (kappa_ 1) were 0.0257 min-1 and 0.0595 min-1, for [3H]-lacidipine and[3H]-isradipine, respectively.5. The non specific binding of [3H]-lacidipine and [3H]-isradipine, was measured in intact rat aorta preparations incubated under the conditions of the functional experiments, in the presence of nifedipine(1 microM). After incubation with [3H]-lacidipine 77.6 +/- 1.9 pM for 2 h the concentration of drug in the tissue was 15.15 +/- 1.18 fmol mg-1 w.wt. and still amounted to 7.24 +/- 0.61 fmol mg-1 w.wt. after 3.5 h washout in drug-free solution. After incubation with [3H]-isradipine 47.2 +/- 0.4 pM for 2 h it was 2.26 +/-0.07 fmol mg-1 w.wt. and was undetectable after 3.5 h washout in a drug-free solution.6. It is concluded that lacidipine interacts reversibly with dihydropyridine binding sites and that the apparent irreversible inhibition of contraction in depolarized preparations could be related to a nonspecific binding in a tissue compartment different from the plasma membrane.
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/8495233-1313732,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8495233-14907713,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8495233-1531693,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8495233-1656465,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8495233-1658191,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8495233-1691398,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8495233-1725443,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8495233-1826619,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8495233-1837846,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8495233-2152924,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8495233-2174553,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8495233-2328404,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8495233-2420337,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8495233-2427250,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8495233-2432624,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8495233-2446799,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8495233-2582076,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8495233-2824756,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8495233-2851351,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8495233-2987659,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8495233-6034324,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8495233-6088117,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8495233-6093156,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8495233-6116136,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8495233-6455156,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8495233-7449765
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Arginine,
http://linkedlifedata.com/resource/pubmed/chemical/Calcium Channel Blockers,
http://linkedlifedata.com/resource/pubmed/chemical/Dihydropyridines,
http://linkedlifedata.com/resource/pubmed/chemical/Isradipine,
http://linkedlifedata.com/resource/pubmed/chemical/Nitroarginine,
http://linkedlifedata.com/resource/pubmed/chemical/Potassium Chloride,
http://linkedlifedata.com/resource/pubmed/chemical/lacidipine
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0007-1188
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
109
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
100-6
|
pubmed:dateRevised |
2009-11-18
|
pubmed:meshHeading |
pubmed-meshheading:8495233-Animals,
pubmed-meshheading:8495233-Arginine,
pubmed-meshheading:8495233-Calcium Channel Blockers,
pubmed-meshheading:8495233-Cell Membrane,
pubmed-meshheading:8495233-Dihydropyridines,
pubmed-meshheading:8495233-Electrophysiology,
pubmed-meshheading:8495233-Isradipine,
pubmed-meshheading:8495233-Kinetics,
pubmed-meshheading:8495233-Male,
pubmed-meshheading:8495233-Microsomes,
pubmed-meshheading:8495233-Mitochondria, Muscle,
pubmed-meshheading:8495233-Muscle, Smooth,
pubmed-meshheading:8495233-Nitroarginine,
pubmed-meshheading:8495233-Potassium Chloride,
pubmed-meshheading:8495233-Radioligand Assay,
pubmed-meshheading:8495233-Rats,
pubmed-meshheading:8495233-Rats, Wistar
|
pubmed:year |
1993
|
pubmed:articleTitle |
Radioligand and functional estimates of the interaction of the 1,4-dihydropyridines, isradipine and lacidipine, with calcium channels in smooth muscle.
|
pubmed:affiliation |
Laboratoire de Pharmacologie, Université Catholique de Louvain, Bruxelles, Belgium.
|
pubmed:publicationType |
Journal Article,
In Vitro,
Research Support, Non-U.S. Gov't
|